FDA Approved: RUBY-FILL — Supplemental Application (Jubilant DraxImage Inc., dba Jubilant Radiopharma)

View source ↗

Summary

FDA approved a supplemental application for RUBY-FILL (rubidium-82) from Jubilant Radiopharma, expanding its approved use related to PET myocardial perfusion im…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease
• Ischemic Heart Disease

Drugs mentioned

• RUBY-FILL (RUBIDIUM RB 82)

Snippet

SUPPL AP for RUBY-FILL (RUBIDIUM RB 82)